Huma Therapeutics Limited, an international company specializing in healthcare technology that combines predictive care and machine learning, has announced the completion of a $130 million (approximately €107 million) capital increase. There is an option to approve an additional capital increase of $70 million (approximately €58 million) to be exercised in the future, which would bring the total capital raised to over $200 million (approximately €165 million). Huma was recently recognized by the Financial Times as the fastest-growing European healthcare company.

Investor portal
* required fields